INTRATUS
DEAD

Serial Number

88446393

Owner

Intratus, Inc.

Attorney

Katharine Tremblay

Filing Date

May 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

INTRATUS Trademark

Serial Number: 88446393

INTRATUS is a trademark filed by Intratus, Inc. on May 24, 2019. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 25 (Clothing). The application is currently no longer active.

Owner Contact Info

Intratus, Inc.

San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 24, 2019

Registration Date

Not Registered

Published for Opposition

March 31, 2020

Goods & Services

Continuing education services, namely, providing live and on-line continuing professional education seminars in the field of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Continuing education services, namely, providing live and on-line continuing professional education seminars in the legal, medical, accounting, and real estate fields; Education services, namely, providing tutorial sessions in the fields of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Providing continuing medical education courses

Anesthetics for non-surgical use; Balms for medical purposes; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical and medical purposes, namely, for Ophthalmology, Allergy and Immunology, Cardiovascular, and Type II Diabetes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emollients that facilitate the delivery of pharmaceutical preparations; Emollients for medical purposes; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular and intraocular surgery; Pharmaceutical preparations for the treatment and prevention of dry eye and glaucoma and other ocular disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for ophthalmic conditions, allergies, immune system diseases, cardiovascular, and type II diabetes; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Topical anesthetics

Cosmetics

Hats; Hoodies; Jackets; Shirts; Sweatshirts; Wearable garments and clothing, namely, shirts

Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Plant extracts for use in the manufacture of creams, lotions and cosmetic products

Clinical medical practice consultation services; Medical clinic services; Medical services; Ophthalmology services; Medical treatment of dry eye and or glaucoma and other ocular disorders; Medical diagnosis and treatment of dry eye and or glaucoma and other ocular disorders

Drug delivery systems; Medical devices for nonsurgical cosmetic treatments; Medical apparatus for introducing pharmaceutical preparations into the human body

Clinical research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Medical research; Medical and scientific research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Scientific research for medical purposes in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 4, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 4, 2025 ABN2
ATTORNEY REVIEW COMPLETED
Oct 16, 2024 ATRV
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Jan 6, 2022 ATRQ
PETITION TO REVIVE DISMISSED
Jan 6, 2022 PR.D
ASSIGNED TO PETITION STAFF
Jan 6, 2022 APET
NOTICE OF REVIVAL - E-MAILED
Nov 27, 2021 NREV
PETITION TO REVIVE-RECEIVED
Nov 26, 2021 PETR
SOU EXTENSION RECEIVED WITH TEAS PETITION
Nov 26, 2021 TPEX
PETITION TO REVIVE-GRANTED
Nov 26, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 26, 2021 PROA
TEAS STATEMENT OF USE RECEIVED
Nov 26, 2021 EISU
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 12, 2021 GNFN
FINAL REFUSAL E-MAILED
Oct 12, 2021 GNFR
SU - FINAL REFUSAL - WRITTEN
Oct 12, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2021 CRFA
ASSIGNED TO LIE
Sep 16, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 13, 2021 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Feb 21, 2021 SUPC
SOU EXTENSION 1 GRANTED
Feb 21, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2021 AITU
NOTICE OF REVIVAL - E-MAILED
Feb 2, 2021 NREV
USE AMENDMENT FILED
Feb 1, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 1, 2021 EISU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Feb 1, 2021 TPEX
PETITION TO REVIVE-GRANTED
Feb 1, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 1, 2021 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 28, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 28, 2020 ABN6
SOU EXTENSION 1 FILED
Nov 27, 2020 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 26, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2020 CRFA
ASSIGNED TO LIE
Feb 21, 2020 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2020 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 15, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 15, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 15, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2019 NWOS
NEW APPLICATION ENTERED
May 28, 2019 NWAP